Related Experiment Video
Updated: Jun 25, 2026

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
Published on: September 25, 2016
Multiparametric Characterization of Tough Clots Following Stroke Thrombectomy
Kianush Karimian-Jazi1, Vasileios Kapralos1, Daniel Schwarz1
1Heidelberg University, Heidelberg, Germany.
Tough clots resistant to thrombectomy are primarily platelet-rich and linked to comorbidities like cancer. Understanding clot composition is key for personalized stroke treatment strategies.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Pathology
Background:
- Mechanical thrombectomy (TE) is standard for large vessel occlusion stroke.
- A subset of clots, termed 'tough clots,' require multiple TE maneuvers, leading to higher complication rates and poorer outcomes.
- The biological characteristics of these tough clots remain poorly understood.
Purpose of the Study:
- To investigate the distinct structural and etiological properties of tough clots resistant to thrombectomy.
- To correlate clot composition with clinical parameters and patient outcomes.
Main Methods:
- Prospective, single-center study analyzing clot composition in 33 ischemic stroke patients.
- Subgroup analysis of 16 'tough clots' using preinterventional imaging, ex vivo high-field MRI (9.4 T MR-microscopy), and histopathology.
- Correlation of imaging findings with clinical data and patient outcomes.
Main Results:
- MR-microscopy revealed predominantly platelet-rich (white) clots (64%), with mixed (27%) and RBC-rich (9%) clots being less common.
- Tough clots were predominantly white (87.5%) and associated with increased procedure time and maneuver count.
- Tough clots were frequently observed in cancer patients (63%) and cardiac patients with periprocedural emboli (67%).
- Stroke patients with cancer undergoing TE had significantly worse outcomes at discharge and 90 days.
Conclusions:
- Tough clots are characterized by a platelet-rich composition and are associated with underlying comorbidities, particularly malignancies.
- Clot composition and pre-existing conditions significantly influence thrombectomy success.
- Individualized stroke management strategies are necessary, considering both clot characteristics and patient comorbidities.
More Related Videos
08:50Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
06:38The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
Published on: December 19, 2025